The occurrence of anti‐CCP in COVID‐19 patients may predict the possible development of RA in the COVID‐19 population with a predisposing genetic background, including patients with specific HLA‐DRB1 alleles (shared epitope). This evidence concerns the gene HLA-DRB1 and COVID-19.